Abstract:Objective The renin-angiotensin system (RAS) is implicated in the development of hypertensive glomerulosclerosis, However, no experimental evidence exists that clearly demonstrates activation of glomerular RAS in hypertensive nephropathy, We used stroke-prone spontaneously hypertensive rats (SHRSP) to examine whether RAS components are increased in glomeruli of SHRSP and whether this increase leads to an increase in mRNA levels for transforming growth factor-beta 1 (TGF-beta 1), Methods We examined the sequential changes of urinary albumin excretion (UAE), morphology, and glomerular mRNA expression for TGF-beta 1 and fibronectin (FN) in relation to glomerular mRNA expression for angiotensinogen (ATN), angiotensin converting enzyme (ACE), angiotensin II type 1a (AT1a), and type 1b (AT1b) receptors, and intervention with angiotensin II type 1. receptor antagonist candesartan and equihypotensive hydralazine, Results In SHRSP, UAE was normal at 9 weeks of age, but became higher, beginning at 12 weeks of age, than that in the age-matched Wistar-Kyoto (WKY) rats, while SH RSP showed no glomerulosclerosis until 14 weeks of age; it was marked at 24 weeks. Plasma renin activity and plasma angiotensin II level was equivalent in the 9- and 12-week-old SHRSP and the WKY rats; both parameters, however, were elevated in 24-week-old SHRSP as compared with age-matched control. RNase protection assays showed that glomerular levels of ATN, ACE, and AT1a and AT1b receptors mRNA were significantly increased in 9-, 12-, and 14-week-old, but not in 24-week-old SHRSP, compared with age-matched WKY rats. Northern blot analysis showed that glomerular levels of TGF-beta 1 and FN mRNA were higher in SHRSP than in WKY rats at all time points. Candesartan reduced UAE to control levels, whereas hydralazine reduced UAE but not to control levels. Candesartan administration for 12 weeks virtually prevented the progression of glomerulosclerosis. While candesartan reduced mRNA levels for RAS components, TGF-beta 1 and FN to control levels, hydralazine was not effective in this respect. Conclusion Results suggest that increases in glomerular RAS components that occur independently of circulating RAS alter glomerular permselectivity and increase the glomerular expression of TGF-PI and FN in young SHRSP. Findings in old SHRSP suggest that altered glomerular permselectivity and an increased glomerular expression of TGF-beta 1 and FN may be associated with the activation of systemic RAS, JHypertens 2000, 18:1247-1255 (C) Lippincott Williams & Wilkins.

Interaction of RAS Activation and Lipid Disorders Accelerates the Progression of Glomerulosclerosis.

Activation of Renin-Angiotensin System is Involved in Dyslipidemia-Mediated Renal Injuries in Apolipoprotein E Knockout Mice and HK-2 Cells

Oxidized High-Density Lipoprotein Enhances Inflammatory Activity in Rat Mesangial Cells

The activation of renin–angiotensin system is involved in hyperlipidemia mediated renal injuries in apolipoprotein E knockout mice

Activation of the renin-angiotensin system is involved in hyperlipidemia-mediated renal injuries in apolipoprotein E knockout mice

Lipid Disorder and Intrahepatic Renin-Angiotensin System Activation Synergistically Contribute to Non-Alcoholic Fatty Liver Disease

Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease

The Potential Role of Retinoic Acid Receptor Α on Glomerulosclerosis in Rats and Podocytes Injury is Associated with the Induction of MMP2 and MMP9.

Activation of Mtor Contributes to Foam Cell Formation in the Radial Arteries of Patients with End-Stage Renal Disease

Chymase Is Upregulated in Diabetic Nephropathy: Implications for an Alternative Pathway of Angiotensin II- Mediated Diabetic Renal and Vascular Disease

Activation Of The Ras Contributes To Peritoneal Fibrosis Via Dysregulation Of Low-Density Lipoprotein Receptor

Renin-Angiotensin System Activation Accelerates Atherosclerosis in Experimental Renal Failure by Promoting Endoplasmic Reticulum Stress-Related Inflammation

Interleukin-1β Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells.

Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.

Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.

Genetically conditioned interaction among microRNA-155, alpha-klotho, and intra-renal RAS in male rats: Link to CKD progression

Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions

The activation of mTOR pathway induced by inflammation accelerates the progression of atherosclerosis in hemodialysis patients

Elevated Transcriptional Co-Activator P102 Mediates Angiotensin II Type 1 Receptor Up-Regulation and Extracellular Matrix Overproduction in the High Glucose-Treated Rat Glomerular Mesangial Cells and Isolated Glomeruli.

Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury Via Disrupting Cellular Cholesterol Homeostasis

Role of RAS/Wnt/β-catenin Axis Activation in the Pathogenesis of Podocyte Injury and Tubulo-Interstitial Nephropathy